glp 1 prostate cancer May Patients Receiving GLP-1 Agonists Be at Lower Risk of Aggressiveness and Progression? Frontiers | GLP-1 Receptor Agonists:

Inhibition of GLP-1 action resulted in a quicker gastric emptying rate and a robust glycemic effect confirmation of its action in regulating blood glucose

This highlights that there could be more potential opportunities around positive allosteric modulation of the GLP-1 receptor

For example, an Ozempic patient who developed NAION and lost their vision in one or both eyes could still file a lawsuit even if their vision did not improve after they stopped taking Ozempic

S., Chae C

Case 2: Due to a national shortage of 1.0 mg semaglutide, a female whose weight was previously stable on phentermine 15mg/topiramate 25mg twice daily plus GLP-1 agonist therapy (i.e., semaglutide) was switched to 5mg tirzepatide in-between clinic visits

In the clinical application of GLP-1RA, the effects of gut microbiota should be considered, and individualized programs should be given